+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report by Brand Type (Sativex, Epidiolex), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and Segment Forecasts, 2022-2028

  • ID: 5534066
  • Report
  • January 2022
  • Region: Global
  • 150 Pages
  • Grand View Research
The global cannabis pharmaceuticals market size is expected to reach USD 127.1 billion by 2028. The market is expected to expand at a CAGR of 104.2% from 2022 to 2028. Rapid growth in applications of cannabis for various indications including pain, inflammation, sleep disorders, anorexia, epilepsy, schizophrenia, and multiple sclerosis is estimated to drive market growth. There is a shift from cannabis herbal preparations to prescription drugs. Demand for processed, quantified, and packaged cannabis products is significantly increasing. Moreover, consumer, as well as regulatory acceptance of cannabis products, is increasing which in turn is positively impacting market growth.



Regulatory acceptance of cannabis products such as Sativex and Epidiolex are improving patient and physician perspectives on cannabis as these drugs are developed and regulated by the stringent process.

The increasing number of research and development activities and clinical trials for studying the therapeutic benefits of cannabis will drive the market growth during the forecast period. For instance, in September 2020, Tilray Inc. announced that its cannabis products are showing promising results in reducing vomiting and nausea in patients undergoing chemotherapy for cancer. According to the study, a quarter of the patients consuming medical cannabis did not show nausea and vomiting. Such research studies are estimated to increase the demand for cannabis in the pharmaceutical industry.

There is a rise in a number of physicians prescribing cannabis to their patients due to increasing clinical evidence, growing awareness, and an increasing number of patients looking for cannabis as a medical alternative. For instance, according to a survey published in 2019, 22% of the consumers were looking for replacing prescription or OTC drugs with CBD. Moreover, 30% took CBD in addition to the prescribed drug. Forty-seven percent replaced an OTC drug with CBD, 36% with prescription opioids, 33% with prescription anxiety drugs, and 22% with prescription sleep drugs. Thus, increasing cannabis consumption will drive the pharmaceutical cannabis market globally.

Regulatory approval of cannabis is a major parameter supporting market growth. Governments and regulatory authorities are taking initiatives to legalize the use of cannabis for medical purposes. For instance, In August 2020, a regulatory authority in Portugal, INFARMED I.P., granted license to Clever Leaves for cultivation and import export of medical cannabis. For instance, in November 2018, GW Pharmaceuticals, plc launched EPIDIOLEX (CBD) oral solution for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. EPIDIOLEX was approved by the FDA in June 2018. It is the first prescription pharmaceutical formulation plant-derived CBD and an antiepileptic drug.

Cannabis Pharmaceuticals Market Report Highlights

  • The Epidiolex brand type emerged as the leading application segment in 2021, with a revenue share of 96.9% in the market
  • Europe dominated the market and accounted for the largest revenue share of 43.8% in 2021
  • In Middle East and Africa, the market is projected to expand at the fastest CAGR during the forecast period


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Cannabis Pharmaceuticals Market

What is the estimated value of the Global Cannabis Pharmaceuticals Market?

The Global Cannabis Pharmaceuticals Market was estimated to be valued at $1750.2 Million in 2022.

What is the growth rate of the Global Cannabis Pharmaceuticals Market?

The growth rate of the Global Cannabis Pharmaceuticals Market is 104.3%, with an estimated value of $127100.0 Million by 2028.

What is the forecasted size of the Global Cannabis Pharmaceuticals Market?

The Global Cannabis Pharmaceuticals Market is estimated to be worth $127100.0 Million by 2028.

Who are the key companies in the Global Cannabis Pharmaceuticals Market?

Key companies in the Global Cannabis Pharmaceuticals Market include GW Pharmaceuticals, AbbVie Inc. and Insys Therapeutics, Inc..

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Global Cannabis Pharmaceuticals Market Outlook
2.2 Global Cannabis Pharmaceuticals Market Segment Outlook
2.3 Global Cannabis Pharmaceuticals Market Competitive Insight
2.4 Global Cannabis Pharmaceuticals Snapshot
Chapter 3 Global Cannabis Pharmaceuticals Market Variables, Trends, & Scope
3.1 Market Segmentation
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Penetration & Growth Prospects Mapping
3.4 Global Cannabis Pharmaceuticals Regulatory Scenario
3.5 Cannabis Pharmaceuticals - PESTEL Analysis
3.5.1. Political
3.5.2. Environmental
3.5.3 Social
3.5.4 Technology
3.5.5. Legal
3.5.6 Economic
3.6 Cannabis Pharmaceuticals - Porter’s Analysis
3.6.1. Threat of New Entrants
3.6.2 Bargaining Power of Buyers
3.6.3 Competitive Rivalry
3.6.4 Bargaining Power of Suppliers
3.6.5 Threat of Substitutes
3.7 Opportunity Analysis (2016 - 2019 - 2027)
3.8 Product Pipeline Analysis, By Stage
3.9 Key Deals and Strategic Alliances
3.10 Synthetic Cannabis Pharmaceuticals Overview
Chapter 4 Global Cannabis Pharmaceuticals Market: Brand Type Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Market: Brand Type Market Share Analysis, 2020 and 2028
4.3 Sativex
4.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
4.4 Epidiolex
4.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 5 Global Cannabis Pharmaceuticals Market: Regional Estimates & Trend Analysis, By Brand Type, Deployment Model and End-user
5.1 Global Cannabis Pharmaceuticals Market: Regional Movement Analysis
5.2 North America
5.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.2.2 U.S.
5.2.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.2.3 Canada
5.2.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3 Europe
5.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.2 U.K.
5.3.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.3 Germany
5.3.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.4 Italy
5.3.4.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.5 France
5.3.5.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.6 Netherland
5.3.6.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.7 Poland
5.3.7.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.8 Croatia
5.3.8.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.9 Czech Republic
5.3.9.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.10 Switzerland
5.3.10.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4 Asia Pacific
5.4.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4.2 Japan
5.4.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4.3 South Korea
5.4.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4.4 Australia
5.4.4.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4.5 New Zealand
5.4.5.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5 Latin America
5.5.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.2 Brazil
5.5.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.3 Mexico
5.5.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.4 Argentina
5.5.4.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.5 Columbia
5.5.5.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.6 Uruguay
5.5.6.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.7 Chile
5.5.7.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.8 Peru
5.5.8.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.6 MEA
5.6.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.6.2 Israel
5.6.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
Chapter 6 Global Cannabis Pharmaceuticals Market: Competitive Analysis
6.1 Company Market Position Analysis
6.2 List of Key Emerging Players and Market Differentiators
6.3 Company Categorization
6.4 Brand Share Analysis, 2018-2020
Chapter 7 Competitive Landscape
7.1 GW Pharmaceuticals
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 AbbVie Inc.
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Valeant Pharmaceuticals
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Insys Therapeutics, Inc.
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 3 U.S. cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 4 Canada cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 5 Europe cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 6 U.K. cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 7 Germany cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 8 Italy cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 9 France cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 10 Netherland cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 11 Poland cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 12 Croatia cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 13 Czech Republic cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 14 Switzerland cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 15 Asia Pacific cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 16 Japan cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 17 South Korea cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 18 Australia cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 19 New Zealand cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 20 Latin America cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 21 Brazil cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 22 Mexico cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 23 Argentina cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 24 Columbia cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 25 Uruguay cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 26 Peru cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 27 Chile cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 28 MEA cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
Table 29 Israel cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Cannabis pharmaceuticals market snapshot, 2020 (USD Million)
FIG. 9 Cannabis pharmaceuticals market segmentation
FIG. 10 Cannabis pharmaceuticals market dynamics
FIG. 11 Cannabis pharmaceuticals market driver impact
FIG. 12 Cannabis pharmaceuticals market restraints impact
FIG. 13 Penetration & growth prospects mapping for cannabis pharmaceuticals market
FIG. 14 Cannabis Pharmaceuticals -PESTL Analysis
FIG. 15 Cannabis Pharmaceuticals -PORTER’s Analysis
FIG. 16 Opportunity analysis (USD Million)
FIG. 17 Cannabis Pharmaceuticals market, brand outlook: Key takeaways
FIG. 18 North America cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 19 U.S. cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 20 Canada cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 21 Europe cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 22 U.K. cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 23 Germany cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 24 France cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
Fig. 25 Italy cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 26 Netherlands cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 27 Poland cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 28 Croatia cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 29 Switzerland cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 30 Czech Republic cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 31 Asia Pacific cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 32 Japan cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 33 South Korea cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 34 Australia cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 35 New Zealand cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 36 Brazil cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 37 Mexico cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 38 Argentina cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 39 Colombia cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 40 Uruguay cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 41 Chile cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 42 Israel cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)

Companies Mentioned

  • GW Pharmaceuticals
  • AbbVie Inc.
  • Valeant Pharmaceuticals
  • Insys Therapeutics, Inc.

Methodology

Loading
LOADING...